ribociclib
novartis
['bcsm', 'natalee']
after the #natalee trial which cdk4/6i will you be offering in the adjuvant setting:
#asco23 #bcsm 
Breast Medical Oncologist @mdandersonnews - Lobular Specialist - Scientific advisor @LobularBCA.